Oculopharyngeal muscular dystrophy in two unrelated Japanese families
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Oculopharyngeal muscular dystrophy (OPMD) (MIM 164300), [1] an autosomal dominant disorder clinically characterized by ptosis and dysphagia, [2] usually manifests insidiously after the fifth decade of life. [3] Involvement of the extraocular muscles early in the course of the disease is uncommon, and cardiac muscles are spared. [2,3] Intranuclear tubulofilamentous inclusions (ITI) within muscle fibers are characteristic of the disease. [4-12] The presence of rimmed vacuoles is indicative, but not specific to OPMD. [3,13,14] Linkage study has shown that the OPMD locus maps to the region of the cardiac alpha and beta myosin heavy chain genes on chromosome 14q11.2-q13. [15] Most of early documented patients with OPMD [16-25] were French-Canadians whose common ancestors emigrated from France to Quebec in 1634. [19] There have been numerous affected families, related or unrelated to French-Canadians, reported from various communities around the world, [2,4,5,8,10-12,26-48] but except for one black family, [48] all were white. There are no morphologically confirmed OPMD cases in Orientals.
We present two unrelated Japanese families with OPMD, and describe the results of the clinicopathologic investigations performed.
Methods.
Case reports.
We identified two affected families who live in areas distant from each other: Family 1 in Kumamoto Prefecture (Southern Japan) and Family 2 in Shizuoka Prefecture (Central Japan). The pedigrees are shown in Figure 1. Each member in the two families descended from unrelated Japanese ancestors, going back at least to the 18th century. There were no consanguineous marriages in the two families. The clinical summaries of patients 1 through 10 are shown in Table 1.
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Sevil Yaşar and Dr. Behnam Sabayan
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
Articles
GCG genetic expansions in Italian patients with oculopharyngeal muscular dystrophyM. Mirabella, G. Silvestri, G. de Rosa et al.Neurology, February 08, 2000 -
Articles
Oculopharyngodistal myopathy is a distinct entityClinical and genetic features of 47 patientsH. Durmus, S.H. Laval, F. Deymeer et al.Neurology, January 17, 2011 -
Articles
A distinctive autosomal dominant vacuolar neuromyopathy linked to 19p13S. Servidei, F. Capon, A. Spinazzola et al.Neurology, September 01, 1999 -
Article
Correlation between PABPN1 genotype and disease severity in oculopharyngeal muscular dystrophyPascale Richard, Capucine Trollet, Tanya Stojkovic et al.Neurology, December 23, 2016